NYSEARCA:HRTS Tema Obesity & Cardiometabolic ETF (HRTS) Price, Holdings, & News $34.67 +0.05 (+0.14%) (As of 09/18/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatings Get Tema Obesity & Cardiometabolic ETF alerts: Email Address About Tema Obesity & Cardiometabolic ETF (NYSEARCA:HRTS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HRTS alerts:Sign Up Key Stats Today's Range$34.57▼$35.2050-Day Range$32.05▼$35.9052-Week Range$26.26▼$36.03Volume8,837 shsAverage Volume25,797 shsMarket Capitalization$65.53 millionAssets Under Management$524,000.00Dividend YieldN/ANet Expense Ratio0.00%Aggregate RatingModerate Buy ETF OverviewThe Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.Read More… This diversified cannabis pioneer could make huge moves soon (Ad)The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. Learn more here. Tema Obesity & Cardiometabolic ETF ExpensesTypeHRTSNYSEARCA ETFsAll ETFsManagement Fee0.00%0.51%0.52%Other Expenses0.00%0.58%0.54%Total Expense0.00%0.73%0.71%Fee Waiver0.00%-0.68%-0.58%Net Expense0.00%0.58%0.59% Receive HRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address HRTS ETF News HeadlinesEli Lilly’s quest for obesity drugs leads to $1B bet on dark genomeSeptember 6, 2024 | seekingalpha.comHRTS: Generating Alpha In Obesity TreatmentJuly 25, 2024 | seekingalpha.comCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. September 18, 2024 | True Gold Republic (Ad)HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of UpsideJuly 19, 2024 | seekingalpha.comWeight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up SupplyMay 29, 2024 | msn.comBlack menopausal women almost 5 times less likely to be on HRT than white womenApril 27, 2024 | yahoo.comSee More Headlines HRTS ETF - Frequently Asked Questions How have HRTS shares performed this year? Tema Obesity & Cardiometabolic ETF's stock was trading at $30.61 at the beginning of the year. Since then, HRTS stock has increased by 13.3% and is now trading at $34.67. View the best growth stocks for 2024 here. How do I buy shares of Tema Obesity & Cardiometabolic ETF? Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Fund Details Issuer Fund NameTema Cardiovascular and Metabolics ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:HRTS Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings40 Fund Statistics Assets Under Management$524,000.00 Average Daily Volume$0.00 Discount/Premium0.43% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares1,890,000Beta0.93 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Top 10 HRTS HoldingsAmgen (NASDAQ:AMGN)Holding Weight: 6.06%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 5.81%Eli Lilly and Company (NYSE:LLY)Holding Weight: 5.43%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 4.44%Novo Nordisk A/SHolding Weight: 4.38%Chugai Pharmaceutical Co LtdHolding Weight: 3.78%BridgeBio Pharma (NASDAQ:BBIO)Holding Weight: 3.61%Ultragenyx Pharmaceutical (NASDAQ:RARE)Holding Weight: 3.49%Cytokinetics (NASDAQ:CYTK)Holding Weight: 3.35%AstraZeneca PLCHolding Weight: 3.16%Full Holdings DetailsHRTS Sector ExposureHRTS Industry Exposure This page (NYSEARCA:HRTS) was last updated on 9/18/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts